Literature DB >> 15908355

Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs.

Stephen T Reece1, Nicole Stride, Pamela Ovendale, Steven G Reed, Antonio Campos-Neto.   

Abstract

Tuberculin shock due to inoculation of Mycobacterium tuberculosis antigens in patients with tuberculosis is a serious syndrome originally described over 100 years ago by Robert Koch. Here, we present experimental evidence that a single M. tuberculosis recombinant protein, CFP-10, triggers this syndrome. Intradermal inoculation of CFP-10 elicits in M. tuberculosis-infected mice high levels of serum tumor necrosis factor alpha and causes tuberculin shock in infected guinea pigs characterized by hypothermia and death within 6 to 48 h after the antigen inoculation. Autopsies of these animals revealed intense polycythemia and hemorrhagic patches in the lung parenchyma, a pathological observation consistent with tuberculin shock. These results point to the possible occurrence of tuberculin shock in sensitive individuals inoculated with highly purified M. tuberculosis recombinant proteins as vaccine candidates or skin test reagents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908355      PMCID: PMC1111880          DOI: 10.1128/IAI.73.6.3301-3306.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  A short history of Robert Koch's fight against tuberculosis: those who do not remember the past are condemned to repeat it.

Authors:  Stefan H E Kaufmann
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

2.  Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide.

Authors:  Vladimir Trajkovic; Gyanesh Singh; Balwan Singh; Sarman Singh; Pawan Sharma
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family.

Authors:  D C Dillon; M R Alderson; C H Day; D M Lewinsohn; R Coler; T Bement; A Campos-Neto; Y A Skeiky; I M Orme; A Roberts; S Steen; W Dalemans; R Badaro; S G Reed
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity.

Authors:  R N Coler; Y A Skeiky; P J Ovendale; T S Vedvick; L Gervassi; J Guderian; S Jen; S G Reed; A Campos-Neto
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

5.  T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.

Authors:  Y A Skeiky; P J Ovendale; S Jen; M R Alderson; D C Dillon; S Smith; C B Wilson; I M Orme; S G Reed; A Campos-Neto
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

6.  Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice.

Authors:  Andre L Moreira; Liana Tsenova; Melles Haile Aman; Linda-Gail Bekker; Sherry Freeman; Bande Mangaliso; Ulf Schröder; Jaishree Jagirdar; William N Rom; Michael G Tovey; Victoria H Freedman; Gilla Kaplan
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

8.  Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis.

Authors:  Kristi M Guinn; Mark J Hickey; Sanjeev K Mathur; Kelly L Zakel; Jeff E Grotzke; David M Lewinsohn; Sherilyn Smith; David R Sherman
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

9.  Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.

Authors:  Yasir A W Skeiky; Mark R Alderson; Pamela J Ovendale; Jeffrey A Guderian; Lise Brandt; Davin C Dillon; Antonio Campos-Neto; Yves Lobet; Wilfried Dalemans; Ian M Orme; Steven G Reed
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

Review 10.  Vaccines for parasitic and bacterial diseases.

Authors:  Steven G Reed; Antonio Campos-Neto
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

View more
  4 in total

1.  Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis.

Authors:  Yun Sang Cho; Karen M Dobos; Jessica Prenni; Hongliang Yang; Ann Hess; Ida Rosenkrands; Peter Andersen; Sung Weon Ryoo; Gill-Han Bai; Michael J Brennan; Angelo Izzo; Helle Bielefeldt-Ohmann; John T Belisle
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

2.  Guinea pig model of Mycobacterium tuberculosis latent/dormant infection.

Authors:  Suely S Kashino; Danielle R Napolitano; Ziedonis Skobe; Antonio Campos-Neto
Journal:  Microbes Infect       Date:  2008-09-06       Impact factor: 2.700

3.  Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?

Authors:  Nira R Pollock; Antonio Campos-Neto; Suely Kashino; Danielle Napolitano; Samuel M Behar; Daniel Shin; Alex Sloutsky; Swati Joshi; Jasmine Guillet; Michael Wong; Edward Nardell
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

Review 4.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.